Related Experiment Video

Updated: Jul 3, 2026

Isolation and Kv Channel Recordings in Murine Atrial and Ventricular Cardiomyocytes
11:33

Isolation and Kv Channel Recordings in Murine Atrial and Ventricular Cardiomyocytes

Published on: March 12, 2013

Novel KCNQ1 mutations in patients after myocardial infarction

Marlena Olszak-Waśkiewicz1, Mirosław Dziuk, Leszek Kubik

  • 1Department of Cardiology, Military Institute of Health Service, Warsaw, Poland. meridiap@interia.pl

Cardiology Journal
|July 25, 2008
PubMed
Abstract

Insights

New intronic mutations in the KCNQ1 gene are linked to a worse clinical course and sudden cardiac arrest (SCA) in myocardial infarction (MI) patients. These findings highlight potential genetic factors influencing post-MI outcomes.

Area of Science:

  • Cardiovascular Genetics
  • Molecular Cardiology
  • Clinical Electrophysiology

Background:

  • Patients with myocardial infarction (MI) face an elevated risk of sudden cardiac death (SCD).
  • Genetic factors, including mutations in cardiac ion channel genes, are implicated in cardiovascular disease progression.

Purpose of the Study:

  • To identify mutations, including intronic variants, within the KCNQ1 gene in post-MI patients.
  • To assess the association between KCNQ1 gene mutations and the clinical course of myocardial infarction.

Main Methods:

  • Genetic analysis of the KCNQ1 gene in 100 Polish patients post-MI.
  • Correlation of identified mutations with clinical data, including sudden cardiac arrest (SCA), ventricular arrhythmias, and QT interval parameters.
  • 24-hour Holter ECG monitoring to evaluate cardiac events and electrophysiological parameters.

Main Results:

  • Six novel KCNQ1 gene mutations were detected: two in exons and four in introns.
  • Intronic mutations in the KCNQ1 gene were significantly associated with a poorer clinical outcome.
  • A higher incidence of sudden cardiac arrest (SCA) was observed in patients with detected intronic mutations.

Conclusions:

  • Novel intronic mutations in the KCNQ1 gene may play a crucial role in the clinical trajectory of patients post-myocardial infarction.
  • These genetic variants represent potential biomarkers for increased risk of adverse cardiac events, including SCA.

More Related Videos

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

Electrocardiogram Recordings in Anesthetized Mice using Lead II04:16

Electrocardiogram Recordings in Anesthetized Mice using Lead II

Published on: June 20, 2020

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...